Olivia Newton-John Cancer Research Institute

Organization name
Olivia Newton-John Cancer Research Institute
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 561-580 of 755 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
561Feb-2018Long-Acting Somatostatin Analog Therapy Differentially Alters 68Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions.Ayati, Narjess ; Lee, Sze Ting ; Zakavi, Rasoul; Pathmaraj, Kunthi ; Al-Qatawna, Louai; Poon, Aurora; Scott, Andrew M 
56229-Jan-2018DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.Tögel, Lars; Nightingale, Rebecca; Wu, Rui; Chüeh, Anderly C; Al-Obaidi, Sheren; Luk, Ian; Dávalos-Salas, Mercedes; Chionh, Fiona; Murone, Carmel ; Buchanan, Daniel D; Chatterton, Zac; Sieber, Oliver M; Arango, Diego; Tebbutt, Niall C ; Williams, David; Dhillon, Amardeep S; Mariadason, John M 
56311-Jan-2018Surveying retracted studies and notices within the field of radiation oncology.Wasiak, Jason; Hamilton, D G; Foroudi, Farshad ; Faggion, C M
564Jan-2018Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.Christidis, Daniel; McGrath, Shannon ; Leaney, Barry; O'Sullivan, Richard; Lawrentschuk, Nathan
565Jan-2018Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.Wallis, Christopher J D; Glaser, Adam; Hu, Jim C; Huland, Hartwig; Lawrentschuk, Nathan; Moon, Daniel; Murphy, Declan G; Nguyen, Paul L; Resnick, Matthew J; Nam, Robert K
566Jan-2018Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors.Ameratunga, Malaka; Chénard-Poirier, Maxime; Moreno Candilejo, Irene; Pedregal, Manuel; Lui, Andrew; Dolling, David; Aversa, Caterina; Ingles Garces, Alvaro; Ang, Joo Ern; Banerji, Udai; Kaye, Stan; Gan, Hui K ; Doger, Bernard; Moreno, Victor; de Bono, Johann; Lopez, Juanita
567Jan-2018Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital.Ow, Darren; Papa, Nathan P; Perera, Marlon ; Liodakis, Peter ; Sengupta, Shomik ; Clarke, Stephen; Bolton, Damien M ; Lawrentschuk, Nathan
568Jan-2018TERT structural rearrangements in metastatic pheochromocytomas.Dwight, Trisha; Flynn, Aidan; Amarasinghe, Kaushalya; Benn, Diana E; Lupat, Richard; Li, Jason; Cameron, Daniel L; Hogg, Annette; Balachander, Shiva; Candiloro, Ida L M; Wong, Stephen Q; Robinson, Bruce G; Papenfuss, Anthony T; Gill, Anthony J; Dobrovic, Alexander ; Hicks, Rodney J; Clifton-Bligh, Roderick J; Tothill, Richard W
5692018Cell Line Models of Molecular Subtypes of Colorectal Cancer.Mooi, Jennifer K ; Luk, Ian Y; Mariadason, John M 
5702018Mcl-1 and Bcl-xLsequestration of Bak confers differential resistance to BH3-only proteins.Hockings, Colin; Alsop, Amber E; Fennell, Stephanie C; Lee, Erinna F; Fairlie, W Douglas; Dewson, Grant; Kluck, Ruth M
5712018Mismatch repair protein defects and microsatellite instability in malignant pleural mesothelioma.Arulananda, Surein; Thapa, Bibhusal ; Walkiewicz, Marzena; Zapparoli, Giada V; Williams, David S ; Dobrovic, Alexander ; John, Thomas 
5722018Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.Ross, David M; Pagani, Ilaria S; Shanmuganathan, Naranie; Kok, Chung H; Seymour, John F; Mills, Anthony K; Filshie, Robin J; Arthur, Christopher K; Dang, Phuong; Saunders, Verity A; Braley, Jodi; Yong, Agnes S; Yeung, David T; White, Deborah L; Grigg, Andrew P ; Schwarer, Anthony P ; Branford, Susan; Hughes, Timothy P
5732018Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.Chan, Kok Fei; Gully, Benjamin S; Gras, Stephanie; Beringer, Dennis X; Kjer-Nielsen, Lars; Cebon, Jonathan S ; McCluskey, James; Chen, Weisan; Rossjohn, Jamie
5742018Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.Perera, Marlon ; McGrath, Shannon ; Sengupta, Shomik ; Crozier, Jack; Bolton, Damien M ; Lawrentschuk, Nathan
5752018Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma.Metaxas, Yannis; Rivalland, Gareth; Klingbiel, Dirk; Kao, Steven; Schmid, Sabine; Nowak, Anna K; Gautschi, Oliver; Bartnick, Tammo; Hughes, Brett G; Bouchaab, Hasna; Rothschild, Sacha; Pavlakis, Nick; Wolleb, Sybille; Petrausch, Ulf; O'Byrne, Kenneth; Froesch, Patrizia; Löffler-Baumann, Melanie; Pratsch-Peter, Susanne; Russell, Prudence; Mingrone, Walter; Savic, Spasenija; Thapa, Bibhusal ; Früh, Martin; Pless, Miklos; von Moos, Roger; Mauti, Laetitia; John, Thomas 
5762018Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of IntralesionalBacillus Calmette-Guérinfollowed by Ipilimumab in Patients with Advanced Metastatic Melanoma.Da Gama Duarte, Jessica; Parakh, Sagun ; Andrews, Miles C; Woods, Katherine; Pasam, Anupama; Tutuka, Candani; Ostrouska, Simone; Blackburn, Jonathan M; Behren, Andreas; Cebon, Jonathan S 
5772018Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control studyPapa, Nathan P; MacInnis, Robert J; English, Dallas R; Bolton, Damien M ; Davis, Ian D; Lawrentschuk, Nathan; Millar, Jeremy L; Severi, Gianluca; Hopper, John L; Giles, Graham G
5782018Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 Therapy.Parakh, Sagun ; Cebon, Jonathan S ; Klein, Oliver 
5792018Novel approaches to undergraduate oncology educationHa, Francis J; Parakh, Sagun 
5802018Landmarks in prostate cancer.Sathianathen, Niranjan J; Konety, Badrinath R; Crook, Juanita; Saad, Fred; Lawrentschuk, Nathan